Highlights from the year, courtesy of our colleagues at Ophthalmology Times

Alcon Laboratories is voluntarily recalling one lot (Lot 10101) of its Systane Lubricant Eye Drops Ultra PF, Single Vials On-the-Go, 25 count, after identifying fungal contamination in a sealed vial.

The top therapeutic advancements in myopia, diabetes, dry eye and more

Trending topics and milestone stories from our year in ophthalmology

The number of patients with retinal vascular diseases is expected to increase over time due to the aging population and lifestyle changes

A panelist discusses novel treatments for retinal vascular diseases, including faricimab, aflibercept, and ranibizumab.

Our top 10 print stories highlight the core content concepts we explored this year

The Danish Medicines Agency requested the EMA's Pharmacovigilance Risk Assessment Committee review reports on the vision-threatening condition

Low-level light therapy for dry eye disease and chalazion

Panelists discuss how aflibercept’s molecular structure contributes to its clinical efficacy as a standard treatment for retinal vascular diseases.

Panelists discuss how anti-VEGF therapies have dramatically improved visual outcomes in patients with age-related macular degeneration and diabetic macular edema over the past decade. Key challenges persist, including treatment burden, adherence, and identifying optimal dosing regimens for individual patients.

The timeline demonstrates international innovation and collaboration

Sophisticated programmes require an evolving mindset

Espansione Group's Light Modulation Low-level Light Therapy (LLLT) is used in ophthalmology and dermatology

Ocular clues to a neurological conditions help clinicians understand neuromyelitis optica spectrum disorder (NMOSD)

The European Commission will assess the marketing authorisation for Eydenzelt (reference product Eylea)